Rajesh C. Shrotriya MD - 15 Jun 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Rajesh C. Shrotriya
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 16:02:33 UTC
Previous filing
14 Feb 2022
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Stock Option (Right to Buy) Award $0 +98 +0.1% $0.000000 98,349 15 Jun 2021 Common Stock 98,349 $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option award will vest ratably quarterly to the end of the year.